Galmed Pharmaceuticals
GLMD
#10043
Rank
A$8.53 M
Marketcap
$5.15
Share price
10.10%
Change (1 day)
-22.33%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$10.10

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$10.53. In 2022 the company made an earnings per share (EPS) of -$16.64 an increase over its 2021 EPS that were of -$31.18.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$10.10-39.32%
2022-$16.64-46.62%
2021-$31.18-2.22%
2020-$31.8839.18%
2019-$22.9170.18%
2018-$13.46-41.84%
2017-$23.15-34.23%
2016-$35.1956.84%
2015-$22.449.2%
2014-$20.55-53.43%
2013-$44.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.03-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.33-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.18-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.72-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA